Related Experiment Video
Updated: Jun 22, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Symptoms in smokers trying to quit
Tanja Tomson1, Mats Toftgård, Hans Gilljam
1Centre for Public Health, Stockholm County Council & Department of Public Health Sciences, Karolinska Institutet, Sweden.
Psychological and neurological symptoms significantly hinder tobacco abstinence, often leading to unsuccessful quit attempts. Nicotine Replacement Therapy (NRT) can effectively reduce these challenging symptoms.
Area of Science:
- Addiction research
- Psychopharmacology
- Public health
Background:
- Tobacco abstinence is challenging due to withdrawal symptoms.
- Understanding symptom dimensions is crucial for effective smoking cessation interventions.
Purpose of the Study:
- To determine the prevalence and intensity of symptoms during tobacco abstinence.
- To identify underlying symptom dimensions in individuals attempting to quit smoking.
Main Methods:
- Cross-sectional study with retrospective self-report questionnaire.
- 12-month assessment period for 741 participants from a national quitline.
- Factor analysis used to explore relationships between 17 reported symptoms.
Main Results:
- High symptom intensity (craving, irritability, anxiety, concentration difficulties, restlessness, depression, insomnia) correlated with unsuccessful quitting.
- Factor analysis revealed three symptom dimensions: psychological (most significant), physiological, and neurological.
- Extended Nicotine Replacement Therapy (NRT) use (≥5 weeks) reduced symptoms within the psychological factor.
Conclusions:
- Interrelated psychological and neurological symptoms are major barriers to successful smoking cessation.
- Nicotine Replacement Therapy (NRT) shows promise in managing these critical symptoms for successful quitting.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Stress Prevention and Stress Management Techniques IV
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
